These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5043110)

  • 1. [Psychoclinical and neurophysiological trials of N-acetyl asparginate of arinine in young subjects with psychopathological, intellectual and character disturbances].
    Boccalatte F; Quatrocolo G; Rolando E; Miano M
    Policlinico Med; 1972; 79(2):87-101. PubMed ID: 5043110
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psychoclinical trials of N-acetyl-asparginate of arginine].
    Rubino A; Criscuoli PM
    Acta Neurol (Napoli); 1967; 22(4):440-9. PubMed ID: 5604345
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of clinical experimentation with arginine N-acetyl-asparaginate (C.E. 387) in 2 groups of mentally deficient children (double blind study)].
    Landry M; Durey D
    Rev Neuropsychiatr Infant; 1966 Sep; 14(9):695-703. PubMed ID: 5334275
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and electroencephalographic studies of Gabob-Diazepam effects on young children with behavior disorders].
    Mille T; Scamoni C; Presazzi A
    Minerva Pediatr; 1973 Apr; 25(13):593-603. PubMed ID: 4708945
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimentation and results obtained with administration of N-acetyl-asparginate combined with a mineralizing, polyvitaminic complex in tuberculous patients of various ages of arginine affected by psycho-clinical and toxic disturbances].
    Fossati C
    Clin Ter; 1974 Apr; 69(2):139-52. PubMed ID: 4599448
    [No Abstract]   [Full Text] [Related]  

  • 6. Haloperidol for control of severe emotional reactions in mentally retarded patients.
    Grabowski SW
    Dis Nerv Syst; 1973; 34(6):315-7. PubMed ID: 4782288
    [No Abstract]   [Full Text] [Related]  

  • 7. [On pseudoimbecility and pseudointelligence as polar forms of manifestations of intellectual inadequacy in adults].
    Dietrich H
    Schweiz Arch Neurol Neurochir Psychiatr; 1968; 102(1):155-65. PubMed ID: 5686567
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and effectiveness of haloperidol for mentally retarded behaviorally disordered and hyperkinetic patients.
    Grabowski SW
    Curr Ther Res Clin Exp; 1973 Nov; 15(11):856-61. PubMed ID: 4201599
    [No Abstract]   [Full Text] [Related]  

  • 9. Adolescents with borderline intellectual functioning: psychopathological risk.
    Masi G; Marcheschi M; Pfanner P
    Adolescence; 1998; 33(130):415-24. PubMed ID: 9706327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Action of phenyl-pyrrolidine pentane on the pedagogic efficiency of the mentally ill].
    Basile HS
    Prensa Med Argent; 1969 Apr; 56(5):222-6. PubMed ID: 5821963
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with a preparation with a structural neurophospholipid base in infantile neuropsychiatry].
    Balestri L; Campanella F; Cocchi A; Invernizzi G
    Riv Sper Freniatr Med Leg Alien Ment; 1969 Feb; 93(1):192-208. PubMed ID: 5402878
    [No Abstract]   [Full Text] [Related]  

  • 13. [Passage from the topological phase to the euclidean phase in infantile graphic expression].
    Ciambelli M; Mastropaolo MG; Sestito L
    Minerva Pediatr; 1973 Aug; 25(28):1234-8. PubMed ID: 4585088
    [No Abstract]   [Full Text] [Related]  

  • 14. Piperacetazine (Quide) in the management of behavioral disorders in mildly retarded institutionalized boys.
    Kurland AA; Goldberg JB
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):798-804. PubMed ID: 4994685
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cognitive and affective characteristics of children with malformation syndrome].
    Tosi B; Maestro S; Marcheschi M
    Minerva Pediatr; 1995 Oct; 47(10):385-92. PubMed ID: 8569638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sulpyride use in a child psychiatric department].
    Pallegroix M; Chavanne J
    Rev Neuropsychiatr Infant; 1973 Jun; 21(6):379-83. PubMed ID: 4713455
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of pyritinol in the treatment of mentally retarded children. Trials in a medicopedagogic institut].
    Hugonenq H; Espinas A; Saias
    Rev Neuropsychiatr Infant; 1974; 22(1):133-9. PubMed ID: 4822231
    [No Abstract]   [Full Text] [Related]  

  • 18. [Regenerating action of highly polymerized desoxyribonucleic acid on the handicapped with multiple deficiencies (intellectual, motor and hypotrophic) in childhood].
    Brauner F; Kohler C; Vallée J
    Bull Acad Natl Med; 1971 Jul; 155(23):565-9. PubMed ID: 4256872
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary results of a drug therapy of a group of school-age mental retardates].
    Bieber G; Cesario S
    Minerva Med; 1969 May; 60(43):2151-63. PubMed ID: 5790874
    [No Abstract]   [Full Text] [Related]  

  • 20. [Calculating disorders in children].
    Dugas M; Guillarme JJ
    Rev Neuropsychiatr Infant; 1970; 18(1):1-4. PubMed ID: 5440132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.